← Eichor
Study identifier: NCT00271622 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Neurodevelopmental and Behavioral Phenotyping Screening Protocol

Condition: Neurologic Disorders · Autism · Neurodegenerative Disease  ·  Sponsor: National Institute of Mental Health (NIMH)

PhaseN/A
Planned participants5000
Who can joinAll sexes, 6 Weeks to no upper limit
Healthy volunteersYes

About this study

The purpose of this protocol is to allow for the careful evaluation of healthy volunteers and individuals with risk for psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorder for specific protocols at NIH.

This description comes directly from the study's public registry record.

Talk to the study team

Margaret J Pekar  ·  (301) 435-7962  ·  pekarm@mail.nih.gov

Genalynne C Mooneyham, M.D.  ·  (301) 435-6651  ·  gena.mooneyham@nih.gov

Always discuss trial participation with your own doctor first.

Locations (1)

National Institutes of Health Clinical CenterBethesda, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00271622